RadNet, Inc.
RDNT
株式のランク
#3213
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
株価
$70.74
時価総額
$5.57B
変化（1日）
2.13%
変化（1年）
-9.81%
国
US
取引 RadNet, Inc. (RDNT)
カテゴリー
Healthcare
RadNet, Inc.（RDNT）のP/E比率
October 2026 時点のP/E比率 TTM -259.51
RadNet, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は -259.51 です。2023 年末時点での P/E は 726.24 でした。
RadNet, Inc. の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | -259.51 | -114.21% |
| 2024 | 1.83K | 151.48% |
| 2023 | 726.24 | 629.66% |
| 2022 | 99.53 | 55.70% |
| 2021 | 63.93 | -195.25% |
| 2020 | -67.11 | -256.00% |
| 2019 | 43.02 | 183.48% |
| 2018 | 15.18 | -99.83% |
| 2017 | 8.93K | 21,555.17% |
| 2016 | 41.26 | 17.48% |
| 2015 | 35.12 | -86.22% |
| 2014 | 254.90 | 726.72% |
| 2013 | 30.83 | 1,982.71% |
| 2012 | 1.48 | -86.55% |
| 2011 | 11.01 | -236.12% |
| 2010 | -8.09 | -75.07% |
| 2009 | -32.44 | 247.95% |
| 2008 | -9.32 | -51.86% |
| 2007 | -19.37 | 23.60% |
| 2006 | -15.67 | 222.14% |
| 2005 | -4.86 | 203.93% |
| 2004 | -1.60 | -80.41% |
| 2003 | -8.17 | 38.63% |
| 2002 | -5.89 | -325.02% |
| 2001 | 2.62 | -61.00% |
| 2000 | 6.71 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 36.15 | -113.93% |
US
|
|
| 39.77 | -115.33% |
US
|
|
| -290.26 | 11.85% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -113.17% |
US
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。